Radiology services provider RadNet, Inc. is making strides in the application of artificial intelligence (AI), with a new division dedicated to developing AI solutions for breast, lung, and prostate cancer screenings. The firm, which also distributes, displays, stores and retrieves digital medical images, operates outpatient imaging centers across the United States. Its services include a range of diagnostic imaging procedures such as magnetic resonance imaging, computed tomography, and nuclear medicine, among others. RadNet has been working to enhance its radiologists' interpretations of images, and the company's latest efforts in AI are expected to further improve the accuracy of its cancer screenings. Founded in 1981, RadNet is headquartered in Los Angeles, California.